发明名称 |
Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
摘要 |
Disclosed is a means for improving the clinical outcomes of cancer therapy. Specifically disclosed is an activity potentiator comprising a compound capable of inhibiting the expression of RFP (RET finger protein) gene or the activity of RFP as an active ingredient. The activity of an anti-cancer agent having an oxidative stress inducing ability can be potentiated by using the anti-cancer agent in combination with the activity potentiator. Further specifically disclosed are a biomarker useful for the recognition of prognosis in a cancer patient and use of the biomarker. |
申请公布号 |
US8936906(B2) |
申请公布日期 |
2015.01.20 |
申请号 |
US201213728048 |
申请日期 |
2012.12.27 |
申请人 |
National University Corporation Nagoya University |
发明人 |
Takahashi Masahide;Kato Takuya;Kikkawa Fumitaka |
分类号 |
C12Q1/68;C07H21/04;C07H21/02 |
主分类号 |
C12Q1/68 |
代理机构 |
Edwards Wildman Palmer LLP |
代理人 |
Edwards Wildman Palmer LLP |
主权项 |
1. A method for estimating prognosis in a cancer patient having colon carcinoma comprising:
determining an amount of RFP (RET finger protein) in a cancer cell from the patient, and comparing the amount of RFP with a reference amount of RFP wherein an increase in RFP relative to the reference amount is indicative for poor prognosis. |
地址 |
Nagoya-shi JP |